Skip to main content

Finepoint Capital LP

SEC CIK
0001608126
Latest filing
Aug 13, 2026

Holdings in Q3 2025

Holdings as of Sep 30, 2025, filed Nov 13, 2025. Long positions only; changes compare share counts with Q2 2025.

Institution overview
Positions
7
−1 vs. Q2 2025
Portfolio value
$543.0M
+$38.7M (+7.7%) vs. Q2 2025
Filed
Nov 13, 2025
SEC
Holdings of Finepoint Capital LP in Q3 2025
SecurityClassSharesValue% of portfolioShare changeActionHistory
QXOQXO, Inc.COM NEW22,295,615$425.0M78.3%+1,142,747+5.4%AddedHistory
RXORXO, Inc.COMMON STOCK7,266,839$111.8M20.6%+7,266,839NewHistory
SLDBSolid Biosciences Inc.COM NEW961,251$5.93M1.1%00.0%UnchangedHistory
ANNAAleAnna, Inc.COM CL A27,717$115.9K<0.1%00.0%UnchangedHistory
ANNAWAleAnna, Inc.*W EXP 12/13/202490,000$111.7K<0.1%00.0%UnchangedHistory
MNYWWMoneyHero Ltd*W EXP 09/13/202895,000$100.0K<0.1%00.0%UnchangedHistory
CLDICalidi Biotherapeutics, Inc.COM1,042$1.58K<0.1%00.0%UnchangedConverted for a 1-for-12 splitHistory

Options (2)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Finepoint Capital LP in Q3 2025
SecurityClassPutsCalls
SPYSPDR S&P 500 ETF TrustETF$804.3M–
iShares Russell 2000 ETF464287655ETF$391.2M–

Sold out since Q2 2025 (2)

Positions held at the end of Q2 2025 that are gone from this filing.

Positions of Finepoint Capital LP sold out since Q2 2025
SecurityClassShares in Q2 2025Value in Q2 2025% of portfolio in Q2 2025History
LLYVKLiberty Live Holdings, Inc.COM LBTY LIV S C537,051$43.6M8.6%History
Ys Biopharma Co LtdG9845F117*W EXP 03/15/202489,999$19.6K<0.1%–